Does Soma Show Up on a Drug Test? Carisoprodol and Testing
Whether Soma (carisoprodol) shows up on a drug test, why it is not on standard panels, when specialised testing detects it and its metabolite meprobamate, and what to disclose.
Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician and Addiction Medicine Specialist, Phuket Island Rehab.
Soma (carisoprodol) does not usually show up on a standard drug test, because most routine drug screens test for a set of common drugs such as amphetamines, opioids, cocaine, and cannabis, and carisoprodol, a prescription muscle relaxant, is not included on standard panels. This means a typical urine drug screen will not detect Soma. However, Soma can be detected if a test specifically looks for carisoprodol or its active metabolite, meprobamate, which the body produces when it breaks down Soma. Specialised tests, sometimes used in pain management, addiction treatment, forensic, or specific monitoring contexts, can detect carisoprodol and meprobamate. How long Soma remains detectable depends on the dose and the individual, but carisoprodol is relatively short-acting while meprobamate lasts longer, so meprobamate may be detectable for a longer period, on the order of a few days, where a relevant test is used. Because Soma has a real potential for abuse and dependence, and because of its sedative effects, it is increasingly included in specific testing in some settings. Anyone taking prescribed Soma who is being drug tested should disclose their prescription, as honesty and documentation are the proper way to handle any testing situation.
Does Soma show up on a drug test?
Soma usually does not show up on a standard drug test. Soma is the brand name for carisoprodol, a prescription muscle relaxant used for the short-term relief of muscle pain and spasms. The reason it generally does not appear on routine drug tests is that most standard drug screens are designed to detect a specific set of common drugs, typically amphetamines, opioids, cocaine, cannabis, and a few others, and carisoprodol is not among the substances included on standard panels. So a typical urine drug screen, of the kind used in many workplace and routine tests, will not usually detect Soma.
However, this does not mean Soma is undetectable. It can be detected if a test specifically looks for carisoprodol or its main active metabolite, meprobamate, which the body produces when it breaks down Soma. Such specialised testing is used in certain contexts. This is an important nuance, and because Soma has a real potential for abuse and dependence, specific testing for it is used more often in some settings than people might expect. This article explains why Soma usually does not show up on standard tests, when and how it can be detected through specific testing for carisoprodol and meprobamate, how long it remains detectable, and what someone taking prescribed Soma should do about drug testing.
Why Soma is not on standard drug panels
The reason Soma usually does not show up on a standard drug test is simply that carisoprodol is not one of the substances that standard panels are designed to detect. Routine drug screens, such as the common urine drug screen, use immunoassay tests that look for specific drug classes, and the typical panel covers substances like amphetamines, opioids, cocaine, cannabis, PCP, and sometimes benzodiazepines and a few others. Carisoprodol, as a muscle relaxant, falls outside these standard categories. It is not an opioid, an amphetamine, or one of the other routinely screened classes, and it does not cross-react with those tests in a way that would produce a positive result. So on a standard panel, Soma simply is not looked for and is not detected.
This is similar to other prescription medications that are not part of standard drug panels: their absence from the test means they will not show up unless the test is specifically expanded to include them. It is worth understanding that the standard drug screen is a limited tool, designed to detect common drugs of abuse, not every possible substance. Carisoprodol’s exclusion from standard panels is the main reason most people taking Soma and facing a routine drug test will find it does not show up. However, given Soma’s abuse potential and sedative effects, it is increasingly recognised as a substance worth testing for in specific situations, which is where specialised testing comes in.
| Question | Soma (carisoprodol) |
|---|---|
| On a standard drug panel? | No: not among routinely screened drugs |
| Detected by specific testing? | Yes: tests for carisoprodol or meprobamate |
| Active metabolite | Meprobamate (a sedative) |
| Carisoprodol detection | Shorter; it is relatively short-acting |
| Meprobamate detection | Longer, on the order of a few days |
| Why testing may be used | Soma’s abuse and dependence potential |
When and how Soma is detected: carisoprodol and meprobamate
Soma can be detected when a test specifically looks for carisoprodol or its metabolite meprobamate. An important feature of Soma is that the body breaks down carisoprodol into meprobamate, a substance that is itself a sedative, related to the barbiturates, and that has its own abuse potential. So testing for Soma can target either the parent drug, carisoprodol, or meprobamate, or both. Specialised laboratory tests, often using techniques such as gas chromatography-mass spectrometry, can identify these substances specifically. Such testing is used in contexts including pain management monitoring, addiction treatment, forensic investigations, and certain other specific monitoring situations where Soma use or misuse is a concern.
Because Soma has a recognised potential for abuse and dependence, and because its sedative effects and dangerous combinations with opioids and benzodiazepines are a concern, testing for carisoprodol and meprobamate is increasingly included in expanded or specialised panels in some treatment and monitoring settings. So while Soma is not on the standard panel, it is not a substance that always escapes detection; in settings specifically concerned about its use, it may well be tested for. For anyone taking Soma, the practical implication is that whether it shows up depends entirely on whether the particular test includes carisoprodol or meprobamate, which standard tests do not but specialised tests can. As with any medication, the proper approach is disclosure of a prescription rather than relying on non-detection.
How long Soma stays detectable
How long Soma remains detectable, where a relevant test is used, depends on the dose, how long and often it has been used, the individual’s metabolism and other characteristics, and whether the test is detecting carisoprodol or meprobamate. Carisoprodol itself is relatively short-acting and is cleared from the body fairly quickly. However, its metabolite meprobamate is longer-lasting, so meprobamate may be detectable for a longer period than carisoprodol. As a general guide, where a test specifically detects these substances, the detection window in urine is on the order of a few days after the last dose, with meprobamate accounting for the longer end of this range, though this is approximate and varies between individuals.
It is important to remember that, for most standard drug tests, these detection times are irrelevant, because the test will not be looking for carisoprodol or meprobamate at all. The detection windows matter only where specialised testing for Soma is used. As with other prescribed medications, the more important consideration than detection time is disclosure of the prescription. Trying to time doses around a test is neither necessary nor advisable for someone taking prescribed Soma, both because it interferes with proper treatment and because the legitimate prescription is the proper explanation for any detected substance. The practical bottom line is that Soma generally does not show up on standard tests, and where specialised testing might detect it, a prescription resolves it.
What to do if you take Soma and face a drug test
If you take prescribed Soma and are facing a drug test, the simplest and proper approach is to disclose your prescription to the testing administrator or medical review officer, ideally before the test, and to provide proof such as the prescription label or a letter from your prescriber. Although Soma generally will not show up on a standard drug screen, disclosing it covers any situation in which specialised testing might detect it, and is good practice for any prescribed medication. There is no need to conceal a legitimately prescribed medication; openness is what ensures any result is correctly interpreted. Honesty and documentation are the key to handling any drug-testing situation while taking prescribed medication.
It is generally not advisable to stop your prescribed Soma before a test or alter your dosing, both because this interferes with your treatment and because, with a legitimate prescription, there is no problem to avoid. However, it is also worth being honest with yourself about your Soma use, because Soma has a genuine potential for dependence and is sometimes misused, particularly alongside opioids or benzodiazepines, a dangerous combination. If your use of Soma has gone beyond what is prescribed, or you are finding it hard to stop, this is worth discussing with your doctor. The bottom line on testing is reassuring for legitimate use: Soma usually does not show up on standard tests, and where specialised testing applies, disclosing your prescription resolves it.
Summary
Soma (carisoprodol) does not usually show up on a standard drug test, because most routine drug screens test for a set of common drugs such as amphetamines, opioids, cocaine, and cannabis, and carisoprodol, a prescription muscle relaxant, is not included on standard panels. So a typical urine drug screen will not detect Soma. However, Soma can be detected if a test specifically looks for carisoprodol or its active metabolite, meprobamate, which the body produces when it breaks down Soma. Specialised tests, sometimes used in pain management, addiction treatment, forensic, or monitoring contexts, can detect carisoprodol and meprobamate. How long Soma remains detectable depends on the dose and the individual, but carisoprodol is relatively short-acting while meprobamate lasts longer, so meprobamate may be detectable for a longer period, on the order of a few days, where a relevant test is used. Because Soma has a real potential for abuse and dependence, specific testing for it is used in some settings. Anyone taking prescribed Soma who is being drug tested should disclose their prescription, as honesty and documentation are the proper way to handle any testing situation.
As Dr. Ponlawat Pitsuwan, addiction medicine specialist at Phuket Island Rehab, puts it, “Soma is not on the standard drug panel, so for a routine test it generally does not show up. But people should not assume it is invisible. Carisoprodol breaks down into meprobamate, a barbiturate-type sedative, and specialised tests, which we increasingly use in pain and addiction settings precisely because Soma is abused, can detect both, with meprobamate hanging around for a few days. As always, the right approach for anyone on a legitimate prescription is simply to disclose it. And if someone’s Soma use has crept beyond what is prescribed, especially with opioids, that is a conversation worth having with their doctor.”
Frequently asked questions
Does Soma show up on a drug test?
Usually not on a standard drug test. Soma (carisoprodol) is a prescription muscle relaxant, and most routine drug screens test for common drugs such as amphetamines, opioids, cocaine, and cannabis, not carisoprodol. So a typical urine drug screen will not detect Soma. However, it can be detected if a test specifically looks for carisoprodol or its metabolite meprobamate, which specialised tests, sometimes used in pain management, addiction treatment, or forensic contexts, can do. Because Soma has a real abuse and dependence potential, such specific testing is used in some settings. Anyone taking prescribed Soma should disclose their prescription, which is the proper way to handle any testing situation.
Why is Soma not on standard drug panels?
Because carisoprodol is not one of the substances standard panels are designed to detect. Routine drug screens use immunoassay tests that look for specific drug classes, typically amphetamines, opioids, cocaine, cannabis, PCP, and sometimes benzodiazepines and a few others. Carisoprodol, as a muscle relaxant, falls outside these standard categories; it is not an opioid or amphetamine and does not cross-react with those tests to produce a positive result. So on a standard panel, Soma is simply not looked for. This is similar to other prescription medications not included on standard panels. Detecting Soma requires a test specifically expanded to include carisoprodol or its metabolite meprobamate.
What is meprobamate and why does it matter for testing?
Meprobamate is the main active metabolite of Soma, the substance the body produces when it breaks down carisoprodol. It is itself a sedative, related to the barbiturates, with its own abuse potential. Meprobamate matters for testing because tests for Soma can target either the parent drug carisoprodol or meprobamate, or both, and because meprobamate is longer-lasting than carisoprodol, it may be detectable for a longer period, on the order of a few days, where a relevant test is used. So a specialised test looking for Soma use may detect meprobamate even after carisoprodol itself has cleared. This is part of why Soma can be detected by specific testing despite being absent from standard panels.
How long does Soma stay in your system?
It depends on the dose, how long and often it has been used, the individual’s metabolism, and whether a test is detecting carisoprodol or meprobamate. Carisoprodol itself is relatively short-acting and is cleared fairly quickly, while its metabolite meprobamate is longer-lasting and may be detectable for longer. Where a test specifically detects these substances, the detection window in urine is on the order of a few days after the last dose, with meprobamate accounting for the longer end, though this is approximate and varies. For most standard drug tests, these windows are irrelevant because the test will not be looking for carisoprodol or meprobamate. Disclosure of a prescription matters more than detection time.
Can Soma be detected in a specialised test?
Yes. While Soma is not on standard panels, it can be detected by specialised laboratory tests that specifically look for carisoprodol or its metabolite meprobamate, often using techniques such as gas chromatography-mass spectrometry. Such testing is used in contexts including pain management monitoring, addiction treatment, forensic investigations, and certain monitoring situations where Soma use or misuse is a concern. Because Soma has a recognised abuse and dependence potential, and its dangerous combinations with opioids and benzodiazepines are a concern, testing for it is increasingly included in expanded panels in some settings. So Soma is not a substance that always escapes detection; whether it shows up depends on whether the specific test includes it.
What should I do about a drug test if I take Soma?
Disclose your prescription. Although Soma generally will not show up on a standard drug screen, telling the testing administrator or medical review officer that you take prescribed Soma, ideally before the test, and providing proof such as the prescription label or a letter from your prescriber, covers any situation in which specialised testing might detect it and is good practice for any prescribed medication. Do not stop your prescribed Soma before a test or alter your dosing, as this interferes with treatment and is unnecessary given the legitimate prescription. If your Soma use has gone beyond what is prescribed, or you are finding it hard to stop, that is worth discussing with your doctor. Honesty and documentation are the key.
Sources
National Library of Medicine (MedlinePlus). Carisoprodol. https://medlineplus.gov/druginfo/meds/a682578.html
Drug Enforcement Administration (DEA). Carisoprodol (Soma) Drug Fact Sheet. https://www.dea.gov/factsheets
Food and Drug Administration (FDA). Soma (carisoprodol) Prescribing Information. https://www.fda.gov/drugs
Substance Abuse and Mental Health Services Administration (SAMHSA). Drug Testing Resources. https://www.samhsa.gov/
Clinical Chemistry / Laboratory Medicine. Drug Testing and Confirmatory Methods. https://www.aacc.org/
National Institute on Drug Abuse (NIDA). Misuse of Prescription Drugs Research Report. https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs
Does Soma show up on a drug test — key entities and related terms
does soma show up on a drug test, Soma, carisoprodol, muscle relaxant, prescription muscle relaxant, meprobamate, metabolite, barbiturate, sedative, drug test, urine drug screen, immunoassay, standard panel, specialised test, expanded panel, gas chromatography-mass spectrometry, GC-MS, detection time, detection window, how long soma stays in system, half-life, short-acting, metabolism, pain management monitoring, addiction treatment, forensic testing, prescription, prescribed medication, disclosure, medical review officer, abuse potential, dependence, opioids, benzodiazepines, drug combination, central nervous system depressant, controlled substance, side effects, MedlinePlus, DEA, FDA, SAMHSA, NIDA, Phuket Island Rehab, Dr. Ponlawat Pitsuwan, prescription muscle, substance abuse, prescribed muscle, effects include, muscle relaxant, abuse potential, potential abuse, relaxant effects, relaxant used, relaxant prescribed, muscle, effects, abuse, use, may, side, pain, hours, drugs